Why is Neuland Labs. falling/rising?

As of 01-Aug, Neuland Laboratories Ltd is experiencing a decline in its stock price, currently at 12,886.00, reflecting a decrease of 415.0 points or 3.12%. The stock has been on a downward trend, losing 7.53% over the last two days and opening with a loss of 2.64% today. It reached an intraday low of Rs 12,236.35, which is an 8% drop. Over the past week, the stock has underperformed with a return of -7.23%, while it has shown a positive return of 8.74% over the last month. Despite a strong historical performance, including a 34.30% return over the past year, the company has faced challenges with negative results in recent quarters, including a significant drop in net sales and profitability.
In the broader market context, the Sensex has only declined by 1.06% over the past week, indicating that Neuland Laboratories Ltd's performance is notably weaker than the benchmark. The pharmaceuticals and drugs sector has also seen a decline of 3.27%, contributing to the stock's poor performance. While the company has a strong ability to service debt and high institutional holdings, its long-term growth prospects are hindered by a low growth rate in net sales and a high valuation relative to its peers. These factors collectively suggest that the stock's recent decline is driven by both sector-wide pressures and company-specific challenges.